Cerebrovascular and cardiovascular pathology in Alzheimer's disease (Q37510081)

20 August 2017

1 reference

title

Cerebrovascular and cardiovascular pathology in Alzheimer's disease (English)

1 reference

20 August 2017

0 references

0 references

1 reference

Jack C de la Torre

1

1 reference

20 August 2017

1 January 2009

1 reference

International Review of Neurobiology

20 August 2017

1 reference

20 August 2017

84

1 reference

20 August 2017

35-48

1 reference

Rethinking the dementia diagnoses in a population-based study: what is Alzheimer's disease and what is vascular dementia?. A study from the kungsholmen project.

20 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

Echocardiographic evaluation of hemodynamic parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

Regional cerebral blood flow reductions, heart failure and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

Vascular risk factors for Alzheimer's disease: an epidemiologic perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

Alzheimer's disease is a vasocognopathy: a new term to describe its nature

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

How do heart disease and stroke become risk factors for Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

White matter lesions and hippocampal atrophy in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

Alzheimer's disease prevalence can be lowered with non-invasive testing.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

Carotid artery ultrasound and echocardiography testing to lower the prevalence of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET).

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

Dementia after stroke: the Framingham Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

Preclinical prediction of Alzheimer's disease using SPECT.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

Cerebral hypoperfusion induces cortical watershed microinfarcts which may further aggravate cognitive decline in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

Cholesterol and Alzheimer's disease--is there a relation?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

Application of positron emission tomography for evaluation of metabolism and blood flow in human brain: normal development, aging, dementia, and stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

How pharmaceutical industry funding affects trial outcomes: causal structures and responses

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

Association of metabolic syndrome with Alzheimer disease: a population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer's disease pathogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2900403-6

7 January 2021

10.1016/S0074-7742(09)00403-6

Identifiers

DOI

1 reference

20 August 2017

1 reference

PubMed ID

19501712